MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(TSV:TELO)

0.0550 +0.0050 (+10.00%)
Streaming Delayed Price Updated: 3:52 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 483,015
Open 0.0500
Bid (Size) 0.0500 (1,150)
Ask (Size) 0.0550 (290)
Prev. Close 0.0500
Today's Range 0.0500 - 0.0550
52wk Range 0.0450 - 0.1600
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
-56.0%
-56.0%
1 Month
-15.4%
-15.4%
3 Month
-26.7%
-26.7%
6 Month
-35.3%
-35.3%
1 Year
-60.7%
-60.7%

More News

Read More
OTCQB Venture Virtual Investor Conference Agenda Announced for August 7th
From Virtual Investor Conferences
Via GlobeNewswire
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation
Via Newsfile
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
Via FinancialNewsMedia
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
Via FinancialNewsMedia
Telo Genomics Announces Achieving Interim Results from Smouldering Myeloma Clinical Study
Via Newsfile
Telo Genomics Announces Full-Services Investor Relations Agreement with Adelaide Capital
Via Newsfile
Topics Artificial Intelligence
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
From FN Media Group LLC
Via GlobeNewswire
Telo Genomics Participates in the 18th International Myeloma Society Workshop 2021
Via Newsfile
Topics Artificial Intelligence
Telo Genomics Engages Clinical and Regulatory Affairs Veteran to Lead the Company's ISO 15189 Certification & CLIA Laboratory Accreditation Undertaking
Via Newsfile
Topics Artificial Intelligence
Telo Genomics Completes First Tranche of Oversubscribed Private Placement
Via Newsfile
Topics Artificial Intelligence
Telo Genomics Announces Co-Authored Publication of a Prospective 5-year Multiple Myeloma Study - Successfully Identifying High Risk versus Low Risk Smoldering Myeloma Patients
Via Newsfile
Topics Artificial Intelligence

Frequently Asked Questions

Is TELO publicly traded?
Yes, TELO is publicly traded.
What exchange does TELO trade on?
TELO trades on the Toronto Venture Stock Exchange
What is the ticker symbol for TELO?
The ticker symbol for TELO is TELO on the Toronto Venture Stock Exchange
What is the current price of TELO?
The current price of TELO is 0.0550
When was TELO last traded?
The last trade of TELO was at 10/29/25 03:52 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story